primidone,"1 and sulthiame.2 The dyskinesias caused by simultaneous administration of phenytoin and sulthiame or succinimides may have been provoked by an increase in the serum level of phenytoin. Very few cases of involuntary movements after administration of carbamazepine have been reported so far. One patient of Lefevre and Gablain'6 developed dyskinesias similar to a "flapping tremor" as a symptom of carbamazepine intoxication. Wendland"' described slurred and the gait ataxic, but nystagmus was not present. The EEG was characterised by a 8-9/s background activity, interspersed with theta and 2-3/s delta waves. Epileptic discharges and focal activity were not observed. Serum levels of the antiepileptic drugs (method: Emit Immunoassay) were: carbamazepine 80-4 ,tmol/1 (19 ,ug/ml), phenobarbitone ,imol/1 (14-3 ,ug/ml), and primidone 17 ,mmol/1 (3.7 ,ug/ml). The carbamazepine value was confirmed by high pressure liquid chromatography. The dose of carbamazepine was gradually reduced and completely withdrawn within 7 days, and the choreoathetoid dyskinesias disappeared. Two months later the patient was re-examined and showed no involuntary movements or psychosis. 
